Sophora flavescens root
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Sophora flavescens root
- DrugBank Accession Number
- DB14565
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Bitter root
- Dogol-evs root
- Ku shen
- Kushen
- Lightyellow sophora root
- Shargal lider root
- Shrubby sophora root
- Sle-tres root
- Sofora zheltovataya root
- Sophora angustifolia root
- Sophora root
- Sophorae flavescentis radix
- Sophorae radix
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bladder Control Sophora flavescens root (4 mg/20g) + Aloe vera leaf (2 mg/20g) + Cnidium monnieri fruit (6 mg/20g) + Phellodendron amurense bark (2 mg/20g) Cream Topical Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Cream Sophora flavescens root (4 g/20g) + Aloe vera leaf (3 g/20g) + Ginkgo biloba (2 g/20g) + Phellodendron amurense bark (5 g/20g) Cream Cutaneous Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US Gynecological Gel Sophora flavescens root (2.5 g/25mL) + Pork collagen (6.25 g/25mL) + Propolis wax (5 g/25mL) + Safflower (3.75 g/25mL) Gel Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Lacto Bella Y Sophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) Gel Vaginal Bella Lab Co., Ltd. 2018-04-27 Not applicable US Psoriasis Sophora flavescens root (4 mg/20g) + Aloe vera leaf (4 mg/20g) + Ginkgo biloba (2 mg/20g) + Phellodendron amurense bark (5 mg/20g) Cream Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Lacto Bella Y Sophora flavescens root (0.0015 g/100mL) + Lactobacillus reuteri (0.6 g/100mL) + Lavender oil (0.8 g/100mL) + Sodium chloride (0.3 g/100mL) Gel Vaginal Bella Lab Co., Ltd. 2018-04-27 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- IYR6K8KQ5K
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Active Not Recruiting Basic Science Aging / Dermatitis / Epigenetic Disorder / Psoriasis 1 4 Completed Treatment Palmoplantar Psoriasis / Psoriasis Vulgaris (Plaque Psoriasis) 1 4 Recruiting Basic Science Healthy Volunteers (HV) / Psoriasis 1 4 Recruiting Treatment Advanced Colorectal Carcinoma 1 4 Recruiting Treatment Psoriasis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical Gel Cutaneous Gel Vaginal Cream Cutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 20, 2018 16:22 / Updated at June 12, 2020 16:53